Filing Flows › Celestica (CLS) › Q4 2025
Celestica (CLS) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 27, 2026
Celestica (CLS) reported revenue of $3.7B for the fourth quarter 2025 (Q4 2025), +44% from a year earlier and +14% from the quarter before. Operating margin was 8.6%, net earnings $268M (7.3% of revenue).
Celestica, Q4 2025: revenue $3.7B (+44% year over year), operating margin 8.6%, net earnings $268M, operating cash flow $251M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.7B | +14% | +44% |
| Gross profit | $433M | +4% | +46% |
| Operating profit | $314M | -3% | +55% |
| Net earnings | $268M | -0.1% | +76% |
| Operating cash flow | $251M | +99% | +75% |
| Free cash flow | $156M | +75% | +63% |
What changed
Revenue was $3.7B in Q4 2025, up 44% year over year and up 14% from the previous quarter. CCS was the largest line at 78% of revenue.
Gross margin was 11.8%, up 0.2 points from a year earlier. Operating profit was $0.31B, a 8.6% margin (up 0.6 points year over year). Of the extra revenue versus a year earlier, 10% reached operating profit, above the 8% margin then. Operating expenses grew 25% against revenue growth of 44%. The fastest-growing cost line was Other operating costs (+35%). Net earnings were $0.27B, up 76% year over year. The effective tax rate was 11.2%.
Operating cash flow was $0.25B (up 75% year over year), 94% of net earnings. Non-cash charges added back $0.05B of depreciation and amortization and $0.01B of share-based compensation. Working capital and other items used $0.08B. Capital expenditures of $0.09B left free cash flow of $0.16B.
Questions
What was Celestica's revenue in the fourth quarter 2025?
Celestica (CLS) reported revenue of $3.7B for the fourth quarter 2025 (Q4 2025), +44% from a year earlier and +14% from the quarter before.
Was Celestica profitable in the fourth quarter 2025?
Operating profit was $314M (8.6% of revenue) and net earnings $268M.
Source: Celestica 10-K on SEC EDGAR.